Cargando…
Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients
BACKGROUND: Sensorineural hearing loss is a well-known side effect of cisplatin (CDDP). There is limited research on the effect of dosing, infusion times, and schedules of cisplatin administration and their impact on hearing loss. METHODS: A retrospective review of 993 pediatric patients’ medical an...
Autores principales: | Camet, Miranda L., Spence, Anne, Hayashi, Susan S., Wu, Ningying, Henry, Jennifer, Sauerburger, Kara, Hayashi, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274419/ https://www.ncbi.nlm.nih.gov/pubmed/34262862 http://dx.doi.org/10.3389/fonc.2021.673080 |
Ejemplares similares
-
Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients
por: Mosleh, Ema, et al.
Publicado: (2023) -
Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021) -
A Dose-Effect Study of Cisplatin Ototoxicity in Albino Guinea Pigs
por: Salehi, Negin, et al.
Publicado: (2020) -
The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin
por: Toplu, Yuksel, et al.
Publicado: (2016) -
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
por: Sheth, Sandeep, et al.
Publicado: (2017)